These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 16611274)

  • 21. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
    Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
    Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome.
    Shah JA; Edwards CM; Probert CS
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):169-73. PubMed ID: 18301295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
    Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
    Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Simple Method for TPMT and ITPA Genotyping Using Multiplex HRMA for Patients Treated with Thiopurine Drugs.
    Skrzypczak-Zielinska M; Borun P; Bartkowiak-Kaczmarek A; Zakerska-Banaszak O; Walczak M; Dobrowolska A; Kurzawski M; Waszak M; Lipinski D; Plawski A; Slomski R
    Mol Diagn Ther; 2016 Oct; 20(5):493-9. PubMed ID: 27307154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients.
    van Dieren JM; van Vuuren AJ; Kusters JG; Nieuwenhuis EE; Kuipers EJ; van der Woude CJ
    Gut; 2005 Nov; 54(11):1664. PubMed ID: 16227370
    [No Abstract]   [Full Text] [Related]  

  • 27. An audit of thiopurine methyltransferase genotyping and phenotyping before intended azathioprine treatment for dermatological conditions.
    Vestergaard T; Bygum A
    Clin Exp Dermatol; 2010 Mar; 35(2):140-4. PubMed ID: 19663853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease.
    Slanar O; Bortlík M; Buzková H; Donoval R; Pechandová K; Sebesta I; Lukás M; Perlík F
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):835-8. PubMed ID: 18600549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
    Kurzawski M; Dziewanowski K; Lener A; Drozdzik M
    Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).
    Marinaki AM; Ansari A; Duley JA; Arenas M; Sumi S; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Sanderson JD
    Pharmacogenetics; 2004 Mar; 14(3):181-7. PubMed ID: 15167706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
    Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.
    Gearry RB; Roberts RL; Barclay ML; Kennedy MA
    Pharmacogenetics; 2004 Nov; 14(11):779-81. PubMed ID: 15564886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ITPA polymorphisms do not predict additional risk beyond TPMT and NUDT15 for thiopurine-induced cytopenia in inflammatory bowel disease.
    Jena A; Grover N; Bhatia P; Singh M; Lad D; Prasad KK; Singh H; Dutta U; Sharma V
    Rev Gastroenterol Mex (Engl Ed); 2024; 89(1):25-30. PubMed ID: 36707393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allele frequency of thiopurine methyltransferase and inosine triphosphate pyrophosphatase gene polymorphisms in Korean patients with inflammatory bowel diseases.
    Cheon JH; Kim JH; Kim BY; Kim SW; Hong SY; Eun CS; Hong SS; Byeon JS; Kim TI; Han DS; Yang SK; Lee KR; Kim WH
    Hepatogastroenterology; 2009; 56(90):421-3. PubMed ID: 19579612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation in the ITPA gene predicts intolerance to azathioprine.
    Marinaki AM; Duley JA; Arenas M; Ansari A; Sumi S; Lewis CM; Shobowale-Bakre M; Fairbanks LD; Sanderson J
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1393-7. PubMed ID: 15571265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.
    Stocco G; Martelossi S; Barabino A; Fontana M; Lionetti P; Decorti G; Malusà N; Bartoli F; Fezzi M; Giraldi T; Ventura A
    Dig Liver Dis; 2005 Dec; 37(12):940-5. PubMed ID: 16202677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK; Zhao J; Zhang LR
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
    Seidman EG
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
    Clunie GP; Lennard L
    Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.